Valneva (VALN) Competitors $5.72 -0.09 (-1.62%) As of 07/3/2025 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VALN vs. AGIO, INDV, IRON, BLTE, IDYA, HRMY, ADPT, SPRY, CNTA, and TARSShould you be buying Valneva stock or one of its competitors? The main competitors of Valneva include Agios Pharmaceuticals (AGIO), Indivior (INDV), Disc Medicine (IRON), Belite Bio (BLTE), IDEAYA Biosciences (IDYA), Harmony Biosciences (HRMY), Adaptive Biotechnologies (ADPT), ARS Pharmaceuticals (SPRY), Centessa Pharmaceuticals (CNTA), and Tarsus Pharmaceuticals (TARS). These companies are all part of the "pharmaceutical products" industry. Valneva vs. Its Competitors Agios Pharmaceuticals Indivior Disc Medicine Belite Bio IDEAYA Biosciences Harmony Biosciences Adaptive Biotechnologies ARS Pharmaceuticals Centessa Pharmaceuticals Tarsus Pharmaceuticals Valneva (NASDAQ:VALN) and Agios Pharmaceuticals (NASDAQ:AGIO) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Which has preferable valuation and earnings, VALN or AGIO? Agios Pharmaceuticals has lower revenue, but higher earnings than Valneva. Valneva is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValneva$186.06M2.61-$13.25M-$1.19-4.80Agios Pharmaceuticals$36.50M57.21$673.72M$11.243.21 Do analysts prefer VALN or AGIO? Valneva presently has a consensus target price of $15.50, indicating a potential upside of 171.17%. Agios Pharmaceuticals has a consensus target price of $58.60, indicating a potential upside of 62.53%. Given Valneva's stronger consensus rating and higher possible upside, research analysts plainly believe Valneva is more favorable than Agios Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Valneva 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Agios Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Which has more risk & volatility, VALN or AGIO? Valneva has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Comparatively, Agios Pharmaceuticals has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Do institutionals and insiders have more ownership in VALN or AGIO? 11.4% of Valneva shares are owned by institutional investors. 14.9% of Valneva shares are owned by insiders. Comparatively, 4.3% of Agios Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is VALN or AGIO more profitable? Agios Pharmaceuticals has a net margin of 1,798.26% compared to Valneva's net margin of -43.08%. Agios Pharmaceuticals' return on equity of -2.75% beat Valneva's return on equity.Company Net Margins Return on Equity Return on Assets Valneva-43.08% -43.05% -16.23% Agios Pharmaceuticals 1,798.26%-2.75%-2.52% Does the media prefer VALN or AGIO? In the previous week, Agios Pharmaceuticals had 8 more articles in the media than Valneva. MarketBeat recorded 8 mentions for Agios Pharmaceuticals and 0 mentions for Valneva. Agios Pharmaceuticals' average media sentiment score of 0.14 beat Valneva's score of 0.00 indicating that Agios Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Valneva Neutral Agios Pharmaceuticals Neutral SummaryAgios Pharmaceuticals beats Valneva on 10 of the 16 factors compared between the two stocks. Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VALN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VALN vs. The Competition Export to ExcelMetricValnevaMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$494.40M$10.51B$5.53B$8.95BDividend YieldN/A2.09%5.38%4.09%P/E Ratio-4.8016.7427.4020.24Price / Sales2.6129.37417.66125.07Price / Cash59.4622.8436.6357.47Price / Book2.373.668.085.67Net Income-$13.25M$235.40M$3.16B$248.47M7 Day Performance-1.45%2.15%2.81%3.29%1 Month Performance-8.54%3.00%3.69%5.18%1 Year Performance-20.53%-10.21%35.30%21.35% Valneva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALNValneva1.6427 of 5 stars$5.72-1.6%$15.50+171.2%-20.5%$494.40M$186.06M-4.80700AGIOAgios Pharmaceuticals4.0879 of 5 stars$33.26-0.6%$58.60+76.2%-14.2%$1.94B$36.50M2.96390Insider TradeINDVIndivior2.1141 of 5 stars$14.74+5.7%$17.00+15.3%+5.4%$1.92B$1.19B-47.551,051High Trading VolumeIRONDisc Medicine3.0961 of 5 stars$52.96-2.8%$96.70+82.6%+23.2%$1.89BN/A-13.5130Analyst ForecastBLTEBelite Bio2.4985 of 5 stars$57.70-2.3%$96.67+67.5%+30.6%$1.88BN/A-42.4310Analyst ForecastGap UpIDYAIDEAYA Biosciences3.5468 of 5 stars$21.02-1.6%$53.42+154.1%-33.6%$1.87B$7M-5.8680HRMYHarmony Biosciences4.5712 of 5 stars$31.60-1.2%$53.63+69.7%+3.9%$1.84B$714.73M12.06200ADPTAdaptive Biotechnologies3.4636 of 5 stars$11.65-1.2%$10.57-9.3%+253.3%$1.79B$178.96M-12.14790Gap UpSPRYARS Pharmaceuticals3.1272 of 5 stars$17.45-4.1%$31.00+77.7%+81.4%$1.79B$89.15M-109.0690Insider TradeHigh Trading VolumeCNTACentessa Pharmaceuticals3.2356 of 5 stars$13.14+0.1%$27.89+112.2%+67.1%$1.75B$6.85M-7.26200TARSTarsus Pharmaceuticals2.2567 of 5 stars$40.51+0.4%$66.67+64.6%+42.0%$1.70B$182.95M-14.8450Positive News Related Companies and Tools Related Companies AGIO Alternatives INDV Alternatives IRON Alternatives BLTE Alternatives IDYA Alternatives HRMY Alternatives ADPT Alternatives SPRY Alternatives CNTA Alternatives TARS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VALN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VALN Stock Alerts